title: The significance of valine 33 as a ligand-specific epitope of transforming growth factor alpha.
abstract: Although binding of epidermal growth factor (EGF) and transforming growth factor alpha (TGFalpha) to the EGF receptor (EGFR) is mutually competitive, their binding is not identical, and their biological activities are not always equivalent. To probe for ligand-specific interactions, we have synthesized analogues of TGFalpha with modifications to the residue lying between the fourth and fifth cysteines (the "hinge"). Although this residue lies in a structurally conserved region of the protein, it is not conserved within the EGFR ligand family. Our results show that in TGFalpha there is a preference for a bulky hydrophobic hinge residue; this contrasts with EGF, for which a hydrogen bond donor functionality is preferred. Sequence analysis of the human EGFR ligands revealed that the nature of the hinge residue correlated with the sequence in the B-loop beta-sheet. As this region is an important determinant in recognition of TGFalpha by the chicken EGFR, we assessed the mitogenicity of the TGFalpha hinge mutants, as well as the other EGFR ligands, using chicken embryo fibroblasts. The preference of the chicken EGFR for TGFalpha hinge mutants with hydrophobic side chains paralleled that of the human EGFR. Betacellulin and heparin-binding EGF-like growth factor also possess an hydrophobic hinge; both were at least as potent as TGFalpha for chicken embryo fibroblasts. EGF and amphiregulin, both with hydrogen bond donor functionalities at their hinge, displayed markedly decreased in potency by comparison with TGFalpha. We propose that EGFR ligands can be subclassified into TGFalpha-like and EGF-like and that this is of functional significance, identifying a potential mechanism whereby EGFR can discriminate between its ligands.
authors.affiliation: Cancer Research Campaign Medical Oncology Unit, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom.
authors.forename: S M
authors.initials: SM
authors.lastname: Puddicombe
authors.forename: S G
authors.initials: SG
authors.lastname: Chamberlin
authors.forename: J
authors.initials: J
authors.lastname: MacGarvie
authors.forename: A
authors.initials: A
authors.lastname: Richter
authors.forename: D R
authors.initials: DR
authors.lastname: Drummond
authors.forename: J
authors.initials: J
authors.lastname: Collins
authors.forename: L
authors.initials: L
authors.lastname: Wood
authors.forename: D E
authors.initials: DE
authors.lastname: Davies
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D002478:Cells, Cultured; D002642:Chick Embryo; D017931:DNA Primers / Q000737:chemistry; D000939:Epitopes; D066246:ErbB Receptors / Q000378:metabolism; D006133:Growth Substances / Q000737:chemistry; D006801:Humans; D008024:Ligands; D008934:Mitogens / Q000737:chemistry; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D017433:Protein Structure, Secondary; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D013329:Structure-Activity Relationship; D016211:Transforming Growth Factor alpha / Q000737:chemistry / Q000276:immunology*; D014633:Valine / Q000737:chemistry
chemical_list: D017931:DNA Primers; D000939:Epitopes; D006133:Growth Substances; D008024:Ligands; D008934:Mitogens; D016211:Transforming Growth Factor alpha; D066246:ErbB Receptors; D014633:Valine